The SalivaDirect™ test was developed at the Yale School of Public Health to enable communities and labs to establish affordable and equitable SARS-CoV-2 testing programs by leveraging their existing resources. Now existing as an independent non-profit, SalivaDirect, Inc. is dedicated to enhancing public health through accessible testing strategies.